Revenue: The sum of all revenue fields included for a company's operating activities.
20/20 Biolabs Inc. (AIDX) had Revenue of 0.35M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
0.35M |
-2.12M |
|
0.29M |
|
0.06M |
|
1.80M |
|
-1.44M |
|
-0.73M |
|
-2.17M |
|
-2.17M |
|
-2.17M |
|
-2.17M |
|
-2.17M |
|
-2.17M |
|
-1.44M |
|
-1.19M |
|
7.66M |
|
7.66M |
|
-0.28 |
|
-0.28 |
|
| Balance Sheet Financials | |
4.70M |
|
0.05M |
|
1.10M |
|
5.80M |
|
2.58M |
|
-- |
|
0.47M |
|
3.05M |
|
2.55M |
|
1.72M |
|
2.76M |
|
5.44M |
|
| Cash Flow Statement Financials | |
-1.29M |
|
-0.01M |
|
4.49M |
|
1.03M |
|
4.22M |
|
3.19M |
|
0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.82 |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
17.80% |
|
-408.45% |
|
-408.45% |
|
-- |
|
-615.45% |
|
-600.11% |
|
-1.29M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
2.78 |
|
1.75 |
|
51.31 |
|
-85.19% |
|
-126.28% |
|
-37.48% |
|
-78.88% |
|
0.51 |
|
-0.17 |
|
-0.17 |
|